Repurposing of human tyrosine kinase inhibitors for neglected diseases: lead discovery for Chagas disease.
Chapter 1: Neglected tropical disease, Chagas disease and target repurposing approach
Published: |
|
---|---|
Online Access: | http://hdl.handle.net/2047/d20005100 |
Similar Items
-
Target repurposing for neglected diseases
Published: () -
Editorial: Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
by: Gildardo Rivera, et al.
Published: (2021-10-01) -
Reoptimization of human kinase inhibitors for the treatment of neglected tropical diseases
Published: () -
Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
by: John J. Ryan, MD
Published: (2016-12-01) -
Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents
by: Hari Krishna Ananthula, et al.
Published: (2018-12-01)